To include your compound in the COVID-19 Resource Center, submit it here.

Ceplene: Phase III

MAXM completed enrollment of 225 patients in an international Phase III (M0104) trial comparing

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE